REG - Frontier IP Group - Total Voting Rights

Frontier IPAnnouncement

30/11/2018 17:30

RNS Number : 0952J
Frontier IP Group plc
30 November 2018
 


30 November 2018
 
 
Frontier IP Group plc
("Frontier IP" or the "Company")
 
Total Voting Rights
 
Frontier IP (AIM: FIPP), which specialises in commercialising university intellectual property, announces that the Company's issued share capital as at the date of this announcement comprises 42,106,372 ordinary shares, with one voting right per share ("Ordinary Shares"). The Company does not hold any ordinary shares in treasury and therefore the total number of Ordinary Shares with voting rights in the Company is 42,106,372.
The above figure of 42,106,372 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:



Frontier IP Group plc


T: 0131 240 1251




Neil Crabb, Chief Executive








Andrew Johnson, Communications & Investor Relations


M: 07464 546 025




www.frontierip.co.uk


















Allenby Capital Limited (Nominated Adviser and Broker)


T: 0203 328 5656




Nick Athanas / Nicholas Chambers (Corporate Finance)








Amrit Nahal (Equity Sales)







Notes to Editors:
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services.  The group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRBXBDBXDXBGIG